《2025年乳腺感染性与炎症性病变管理指南》解读OA

Infectious and inflammatory breast diseases are a group of clinically common conditions whose management is highly controversial,and for which standardized evidence-based guidelines have long been lacking.In 2025,the American Society of Breast Surgeons(ASBrS),Society of Breast Imaging(SBI),and College of American Pathology(CAP)jointly issued the 2025 Guidelines for the Management of infectious and inflammatory lesions of the breast,which focus on the three most common conditions—lactational mastitis(LM),granulomatous mastitis(GM),and periductal mastitis with squamous metaplasia of lactiferous ducts(PDM-SMOLD)—and propose a standardized diagnostic and management pathway centered on minimizing invasive interventions.This article interpreted the key points of the guidelines and compared them with the domestic Clinical Practice Guidelines for the Diagnosis and Treatment of Inflammatory Breast Diseases(2025 Edition),to provide insights for clinical practice in China.